The Exchange has sought clarification from Balaji Amines Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is awaited.
BALAMINES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 0.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NSE has asked Balaji Amines Limited to clarify discrepancies found in the XBRL-formatted financial results submitted for the quarter ended 30 June 2025. The query is raised under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, which governs the manner of submitting quarterly financial results. As of now, the company's response to the exchange is awaited.
This is a procedural compliance query and not a penalty or regulatory action. It may cause minor short-term uncertainty around the stock until the company provides a satisfactory clarification, but it does not indicate any fundamental business or governance concern.